FDA OK's Diabetic Neuropathy Capsaicin Patch; EDCs Still a Threat

(MedPage Today) -- The FDA approved an 8% capsaicin patch (Qutenza) for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults, Grünenthal and Averitas Pharma announced.
During the pandemic...

Source link

Related posts

As Schools Reopen, Many Students, Staff Live With High-Risk Family Member


ASH: Research revises classification of acute myeloid leukemia and myelodysplastic syndrome


Early Talk, Interaction Predicts School-Age Language Outcomes


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy